Literature DB >> 23810243

CD47 and osteopontin expression in diffuse large B-cell lymphoma with nodal and intravascular involvement.

Jason S Starr1, Liuyan Jiang, Zhimin Li, Yushi Qiu, David M Menke, Han W Tun.   

Abstract

Entities:  

Keywords:  CD47; Diffuse large B-cell lymphoma; Osteopontin; non-Hodgkin lymphoma

Mesh：

Substances：

Year:  2013        PMID： 23810243     DOI： 10.1016/j.clml.2013.05.001

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN： 2152-2669


× No keyword cloud information.
  5 in total

1.  Intravascular Large B Cell Lymphoma with CNS Involvement Successfully Treated with High-Dose Methotrexate and High-Dose Ara-C Based CNS-Directed Chemoimmunotherapy Alternating with Anthracycline Based Chemoimmunotherapy.

Authors:  Jing Wang; Muhamad Alhaj Moustafa; Justin J Kuhlman; Karan Seegobin; Liuyan Jiang; Vivek Gupta; Han W Tun
Journal:  Blood Lymphat Cancer       Date:  2022-05-25

2.  PD-L1 and CD47 co-expression predicts survival and enlightens future dual-targeting immunotherapy in non-small cell lung cancer.

Authors:  Zhenlin Yang; Yue Peng; Wei Guo; Jiachen Xu; Lin Li; He Tian; Renda Li; Lei Liu; Fengwei Tan; Shugeng Gao; Jie He
Journal:  Thorac Cancer       Date:  2021-05-12       Impact factor: 3.500

3.  Osteopontin expression and its relationship with prognostic factors in diffuse large B-cell lymphoma.

Authors:  Gilberto Barranco; Edith Fernández; Silvia Rivas; Roxana Quezada; Dolores Nava; José Aguilar; Abelardo García; Horacio Astudillo; Carmen Lome; Erika Ruiz
Journal:  Hematol Rep       Date:  2019-09-18

4.  Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003-2018).

Authors:  Karan Seegobin; Zhuo Li; Muhamad Alhaj Moustafa; Umair Majeed; Jing Wang; Liuyan Jiang; Justin Kuhlman; David Menke; Ke Li; Mohamed A Kharfan-Dabaja; Ernesto Ayala; Madiha Iqbal; Grzegorz S Nowakowski; Thomas M Habermann; Thomas E Witzig; Patrick Johnston; Carrie Thompson; Stephen Ansell; Han W Tun
Journal:  Am J Hematol       Date:  2022-07-06       Impact factor: 13.265

Review 5.  Targeting the CD47-SIRPα signaling axis: current studies on B-cell lymphoma immunotherapy.

Authors:  Jin Zhang; Shenhe Jin; Xiaojun Guo; Wenbin Qian
Journal:  J Int Med Res       Date:  2018-09-18       Impact factor: 1.671
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.